Reports for APOTEX INC

Formerly known as AA PHARMA INC

Company Name
APOTEX INC

Shortage reports

Actual shortage:

220 (7%)

Anticipated shortage:

0 (0%)

Avoided shortage:

10 (0%)

Resolved:

3124 (93%)

3354

Discontinuation Reports

To be discontinued:

26 (7%)

Discontinued:

343 (93%)

Reversed:

0 (0%)

369

145 (4%)

73 (30%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-QUETIAPINE 200MG TABLET Resolved 2017-09-04 2018-01-24 20888
APO-QUETIAPINE 100MG TABLET Resolved 2017-05-02 2017-06-27 8702
APO-QUETIAPINE 200MG TABLET Resolved 2018-02-13 2018-04-18 39669
APO-QUETIAPINE 100MG TABLET Resolved 2017-10-18 2018-01-13 26195
APO-QUETIAPINE 300MG TABLET Actual shortage 2021-08-27 2021-08-27 144779
APO-QUETIAPINE 25MG TABLET Actual shortage 2021-08-27 2021-08-27 144776
APO-QUETIAPINE 100MG TABLET Resolved 2019-12-05 2019-12-09 100317
APO-QUETIAPINE 25MG TABLET Resolved 2017-09-27 2018-01-03 23635
APO-QUETIAPINE 25MG TABLET Resolved 2021-04-30 2021-05-31 138352
APO-QUETIAPINE 25MG TABLET Resolved 2018-12-27 2020-10-24 70537
APO-QUETIAPINE FUMARATE 300MG TABLET (IMMEDIATE RELEASE) Actual shortage 2024-01-19 2024-02-23 216708
APO-QUETIAPINE FUMARATE 200MG TABLET (IMMEDIATE RELEASE) Actual shortage 2024-01-19 2024-09-05 216705
APO-QUETIAPINE FUMARATE 100MG TABLET (IMMEDIATE RELEASE) Actual shortage 2024-01-19 2024-09-05 216702
APO-QUETIAPINE FUMARATE 25MG TABLET (IMMEDIATE RELEASE) Actual shortage 2024-01-19 2024-02-23 216699
APO-QUETIAPINE FUMARATE 25MG TABLET (IMMEDIATE RELEASE) Resolved 2023-03-09 2023-04-14 186586
APO-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-03-11 2022-04-06 156549
APO-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-03-11 2022-04-06 156543
APO-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-19 2024-07-18 216696
APO-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-19 2024-11-14 216693
APO-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2019-01-30 2020-11-03 74033
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-FENTANYL MATRIX 25MCG PATCH Discontinued 2018-09-07 2018-09-15 60489
APO-FENTANYL MATRIX Discontinued 2018-09-07 2018-09-15 60494
APO-FENTANYL MATRIX 75MCG PATCH Discontinued 2018-09-07 2018-09-15 60497
APO-FENTANYL MATRIX 100MCG PATCH Discontinued 2018-02-23 2018-12-28 40741
APO-FLUNISOLIDE NASAL SPRAY 0.25MG METERED-DOSE PUMP Discontinued 2018-02-26 2018-02-26 40965
APO-FLUVOXAMINE TABLETS 100MG TABLET Discontinued 2017-03-30 2018-02-05 4713
APO-FLUVOXAMINE TABLETS 50MG TABLET Discontinued 2017-03-30 2018-02-05 4716
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2018-02-26 2018-02-26 40997
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2019-01-02 2019-01-02 70815
APO-GEMFIBROZIL 600MG TABLET Discontinued 2017-03-31 2017-03-31 4927
APO-GEMFIBROZIL CAP 300MG USP Discontinued 2019-06-12 2019-06-12 86557
APO-GEMFIBROZIL CAP 300MG USP 300MG CAPSULE Discontinued 2017-03-31 2018-12-07 4920
APO-GLICLAZIDE 80MG TABLET Discontinued 2018-09-07 2018-09-15 60512
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94452
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94446
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94449
APO-HALOPERIDOL TAB 2MG 2MG TABLET Discontinued 2017-03-13 2017-03-13 1084
APO-HALOPERIDOL TAB 5MG 5MG TABLET Discontinued 2017-03-13 2017-03-13 1087
APO-HYDROMORPHONE CR 24MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110968
APO-HYDROMORPHONE CR 30MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110971